(1R,2S)-2-phenylcyclohexyl alpha-3-hydroxycarbonyl-2,4-di(2-bromophenyl)-cyclobutane-1-carboxylate

ID: ALA4283633

Chembl Id: CHEMBL4283633

PubChem CID: 145989925

Max Phase: Preclinical

Molecular Formula: C30H28Br2O4

Molecular Weight: 612.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)[C@H]1[C@H](c2ccccc2Br)[C@H](C(=O)O[C@@H]2CCCC[C@H]2c2ccccc2)[C@H]1c1ccccc1Br

Standard InChI:  InChI=1S/C30H28Br2O4/c31-22-15-7-4-13-20(22)25-27(29(33)34)26(21-14-5-8-16-23(21)32)28(25)30(35)36-24-17-9-6-12-19(24)18-10-2-1-3-11-18/h1-5,7-8,10-11,13-16,19,24-28H,6,9,12,17H2,(H,33,34)/t19-,24+,25-,26-,27-,28-/m0/s1

Standard InChI Key:  LZAAEAPNMLXUHE-YEGVEROJSA-N

Alternative Forms

  1. Parent:

    ALA4283633

    ---

Associated Targets(Human)

FABP3 Tchem Fatty acid binding protein muscle (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FABP5 Tchem Fatty acid binding protein epidermal (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FABP7 Tchem Fatty acid-binding protein, brain (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 612.36Molecular Weight (Monoisotopic): 610.0354AlogP: 7.68#Rotatable Bonds: 6
Polar Surface Area: 63.60Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.18CX Basic pKa: CX LogP: 8.05CX LogD: 4.60
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.29Np Likeness Score: 0.37

References

1. Yan S, Elmes MW, Tong S, Hu K, Awwa M, Teng GYH, Jing Y, Freitag M, Gan Q, Clement T, Wei L, Sweeney JM, Joseph OM, Che J, Carbonetti GS, Wang L, Bogdan DM, Falcone J, Smietalo N, Zhou Y, Ralph B, Hsu HC, Li H, Rizzo RC, Deutsch DG, Kaczocha M, Ojima I..  (2018)  SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.,  154  [PMID:29803996] [10.1016/j.ejmech.2018.04.050]

Source